These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9299400)

  • 1. A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans.
    Kawauchi K; Shibutani K; Yagisawa H; Kamata H; Nakatsuji S; Anzai H; Yokoyama Y; Ikegami Y; Moriyama Y; Hirata H
    Biochem Biophys Res Commun; 1997 Aug; 237(3):543-7. PubMed ID: 9299400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressant.
    Azuma T; Watanabe N; Yagisawa H; Hirata H; Iwamura M; Kobayashi Y
    Immunopharmacology; 2000 Jan; 46(1):29-37. PubMed ID: 10665777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
    Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
    Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human breast cancer cell lines.
    Yamamoto D; Kiyozuka Y; Uemura Y; Yamamoto C; Takemoto H; Hirata H; Tanaka K; Hioki K; Tsubura A
    J Cancer Res Clin Oncol; 2000 Apr; 126(4):191-7. PubMed ID: 10782891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycloprodigiosin hydrochloride obtained from Pseudoalteromonas denitrificans is a potent antimalarial agent.
    Kim HS; Hayashi M; Shibata Y; Wataya Y; Mitamura T; Horii T; Kawauchi K; Hirata H; Tsuboi S; Moriyama Y
    Biol Pharm Bull; 1999 May; 22(5):532-4. PubMed ID: 10375177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloprodigiosin hydrocloride suppresses tumor necrosis factor (TNF) alpha-induced transcriptional activation by NF-kappaB.
    Kamata K; Okamoto S; Oka S; Kamata H; Yagisawa H; Hirata H
    FEBS Lett; 2001 Oct; 507(1):74-80. PubMed ID: 11682062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycloprodigiosin hydrochloride activates the Ras-PI3K-Akt pathway and suppresses protein synthesis inhibition-induced apoptosis in PC12 cells.
    Kawauchi K; Tobiume K; Iwashita K; Inagaki H; Morikawa T; Shibukawa Y; Moriyama Y; Hirata H; Kamata H
    Biosci Biotechnol Biochem; 2008 Jun; 72(6):1564-70. PubMed ID: 18540098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycloprodigiosin hydrochloride, H(+)/CL(-) symporter, induces apoptosis and differentiation in HL-60 cells.
    Yamamoto D; Uemura Y; Tanaka K; Nakai K; Yamamoto C; Takemoto H; Kamata K; Hirata H; Hioki K
    Int J Cancer; 2000 Oct; 88(1):121-8. PubMed ID: 10962449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of AP-1 activity by cycloprodigiosin hydrochloride.
    Kawauchi K; Tobiume K; Kaneko S; Kaneshiro K; Okamoto S; Ueda E; Kamata H; Moriyama Y; Hirata H
    Biol Pharm Bull; 2007 Sep; 30(9):1792-5. PubMed ID: 17827742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro.
    Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Nakai K; Baden T; Kamata K; Hirata H; Watanabe T; Inoue K
    Oncol Rep; 2001; 8(4):821-4. PubMed ID: 11410791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects induced by cycloprodigiosin hydrochloride and epirubicin on human breast cancer cells.
    Yamamoto D; Tanaka K; Nakai K; Baden T; Inoue K; Yamamoto C; Takemoto H; Kamato K; Hirata H; Morikawa S; Inubushi T; Hioki K
    Breast Cancer Res Treat; 2002 Mar; 72(1):1-10. PubMed ID: 12000216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
    Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T
    Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
    Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
    J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular apoptosis-inducing factor is induced by a vacuolar type H+-ATPase inhibitor in B lineage cells.
    Hashimoto S; Ishisaki A; Yamato K; Aiko K; Amagasa T; Nishihara T
    J Cell Physiol; 2001 Jan; 186(1):65-72. PubMed ID: 11147815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-2 regulated proteins in immunosuppression by the N-alkylated prodigiosin analogue.
    Pandey R; Chander R; Sainis KB
    Int Immunopharmacol; 2007 Dec; 7(13):1695-703. PubMed ID: 17996679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive factors secreted by human amniotic epithelial cells.
    Li H; Niederkorn JY; Neelam S; Mayhew E; Word RA; McCulley JP; Alizadeh H
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):900-7. PubMed ID: 15728546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation.
    Acuña-Castillo C; Aravena M; Leiva-Salcedo E; Pérez V; Gómez C; Sabaj V; Nishimura S; Pérez C; Colombo A; Walter R; Sierra F
    Mech Ageing Dev; 2005 Dec; 126(12):1284-91. PubMed ID: 16140359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
    J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prodigiosin 25-C on cultured cell lines: its similarity to monovalent polyether ionophores and vacuolar type H(+)-ATPase inhibitors.
    Kataoka T; Magae J; Kasamo K; Yamanishi H; Endo A; Yamasaki M; Nagai K
    J Antibiot (Tokyo); 1992 Oct; 45(10):1618-25. PubMed ID: 1473989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.